Related Experiment Video
Updated: Apr 18, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Epithelial to mesenchymal transition in tumor cells as consequence of phenotypic instability
1Programa de Recerca en Càncer, Departament de Ciències Experimentals i de la Salut, Institut Hospital del Mar d'investigacions Mèdiques, Universitat Pompeu Fabra Barcelona, Spain.
Abstract:
During the last years many articles have reported epithelial-to-mesenchymal transitions (EMT) induced by a myriad of gene products either when added to the cell medium or when transfected. Molecularly the EMT is characterized by the up-regulation of transcriptional factors (EMT-TFs) repressing the epithelial gene E-cadherin, a protein essential for the maintenance of the epithelial phenotype. These EMT-TFs are subjected to a complex regulation involving binary self-stimulatory loops, allowing the possibility of the amplification of input signals. The capability of EMT-TFs to promote an EMT is controlled by E-cadherin that limits the transcription of mesenchymal genes. We discuss here the differences between normal and tumor epithelial cells; in the latter a partial inactivation of E-cadherin function enables extracellular signals to be amplified and induce an EMT. This tumor cell phenotypic instability is exacerbated in cell culture conditions. Therefore, it is likely that many of the gene products reported to control this transition act only in very specific cell tumor cell lines; thus, in cells with an unstable phenotype due to pre-existing alterations in E-cadherin safeguard mechanism.
Insights
Epithelial-to-mesenchymal transitions (EMT) involve gene products that repress E-cadherin, crucial for epithelial cells. Tumor cells with altered E-cadherin are more susceptible to EMT induction.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Epithelial-to-mesenchymal transition (EMT) is a cellular process involving gene products that repress E-cadherin.
- E-cadherin is vital for maintaining the epithelial phenotype and its repression is a hallmark of EMT.
- EMT-transcription factors (EMT-TFs) are complexly regulated, involving self-stimulatory loops for signal amplification.
Purpose of the Study:
- To discuss the differences between normal and tumor epithelial cells concerning EMT.
- To explain how partial E-cadherin inactivation in tumor cells amplifies extracellular signals and induces EMT.
- To highlight the role of cell culture conditions in exacerbating tumor cell phenotypic instability.
Main Methods:
- Literature review and discussion of existing research on EMT.
- Analysis of molecular mechanisms underlying EMT, focusing on E-cadherin and EMT-TFs.
- Comparative discussion of normal versus tumor epithelial cell behavior.
Main Results:
- Tumor epithelial cells exhibit phenotypic instability due to partial E-cadherin inactivation.
- Extracellular signals are amplified in tumor cells with compromised E-cadherin, leading to EMT.
- Many reported EMT-inducing gene products may only be effective in specific tumor cell lines with pre-existing E-cadherin defects.
Conclusions:
- E-cadherin acts as a gatekeeper, limiting mesenchymal gene transcription and controlling EMT progression.
- Tumor cell phenotypic instability is a key factor in their susceptibility to EMT.
- The context of E-cadherin function is critical for understanding EMT induction in cancer cells.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cellular Adaptation IV: Dysplasia and Metaplasia

